There has been a reset of expectations around Novo Nordisk (NYSE: NVO) (CPH: NOVOb), which is no longer an obesity ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE